Press Releases

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Cautionary Note Regarding Certain Previously Reported Financial Results -- Investors and others should not rely on annual or quarterly financial information published for the fiscal years ended June 28, 2014 and June 27, 2015; the transition period from June 28, 2015 to December 31, 2015; and the quarterly periods ended December 28, 2013, March 29, 2014, September 27, 2014, December 27, 2014, March 28, 2015, September 26, 2015, April 2, 2016, July 2, 2016 and October 1, 2016. See the Form 10-K and Q1 2016 Form 10-Q/A, Q2 2016 Form 10-Q/A and Q3 2016 Form 10-Q/A filed on May 22 and 23, 2017.

 

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004 / 2003 / 2002 / 2001 / 2000

2009 Archives

Dec 7, 2009
Gluten-free labeling program an industry first for over-the-counter pharmaceuticals
Nov 9, 2009
In the news release, Perrigo Company to Present at the Credit Suisse 18th Annual Health Care Conference, issued 09-Nov-2009 by Perrigo Company over PR Newswire, we are advised by the company that in the first paragraph, the conference date and time should
Aug 18, 2009
- Full-year revenue from continuing operations increased $277 million, or 16 percent, to a record $2 billion - Adjusted income from continuing operations for the full year increased 13 percent to $175 million, or $1.87 per share - GAAP income from continu
 

print email rss
Price Data
NYSEPRGO
Key Contacts
Bradley Joseph
Vice President, Global Investor Relations
269-686-3373
bradley.joseph@perrigo.com
Arthur J. Shannon, Vice President
Global Corporate Affairs and European Investor Relations
(269) 686-1709
ajshannon@perrigo.com